Literature DB >> 17417991

A low prevalance of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings.

I H Köker1, O N Pamuk, C Karlikaya, N Tunçbilek, N Cakir.   

Abstract

OBJECTIVES: In this study, we aimed to evaluate the frequency of purified protein derivative (PPD) skin test positivity and associated clinical features in RA patients.
MATERIALS AND METHODS: We included 94 (80 F, 14 M, mean age: 55.8) consecutive RA patients with a disease duration of 8.7 years. PPD test was performed in all RA patients; clinical features were recorded down; chest x-ray, pulmonary function tests and HRCT were available in all cases. As the control group, we included data of 21 SLE, 44 AS, 27 OA, 16 gouty arthritis and 18 vasculitis patients.
RESULTS: The frequencies of PPD positivity in RA (29.8%) and SLE (19%) patients were lower than in patients with AS (65.9%), gouty arthritis (68.8%) and OA (63%) (all p values < 0.01). PPD-positive RA patients were more frequently smokers (p = 0.005) and had a higher rate of RF seropositivity (p = 0.04) than PPD-negatives. PPD was less frequently positive in erosive RA disease (p = 0.033). Chest x-rays and HRCT abnormalities were detected in 41.8% and 62.7% of RA patients, respectively. Frequencies of chest x-ray and HRCT abnormalities in PPD-positive and PPD-negative patients were not different from each other (p > 0.05).
CONCLUSION: In our country in which tuberculosis is relatively frequent -contrary to the situation in AS patients- we observed a lower frequency of PPD positivity in RA and SLE patients compared to patients with other rheumatic diseases. We did not find any relationship between PPD positivity and the frequency of chest x-ray, HRCT abnormalities.

Entities:  

Mesh:

Year:  2007        PMID: 17417991

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Authors:  Cláudia Diniz Lopes Marques; Ângela Luzia Branco Pinto Duarte; Virginia Maria Barros de Lorena; Joelma Rodrigues Souza; Wayner Vieira Souza; Yara de Miranda Gomes; Eduardo Maia Freese de Carvalho
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

2.  Tuberculosis after anti-TNF therapy.

Authors:  Omer Nuri Pamuk; Salim Dönmez
Journal:  Clin Rheumatol       Date:  2009-03-20       Impact factor: 2.980

3.  Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.

Authors:  Christiane Aguiar Nobre; Maria Roseli Monteiro Callado; José Rubens Costa Lima; Kirla Wagner Poti Gomes; Germana Vasconcelos Mesquita Martiniano; Walber Pinto Vieira
Journal:  Rheumatol Int       Date:  2011-08-07       Impact factor: 2.631

4.  Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents.

Authors:  Giovana Garziera; André Luis Bittencourt Morsch; Felipe Otesbelgue; Fernanda Luiza Staub; Penélope Esther Palominos; Claiton Viegas Brenol; Denise Rossato Silva
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

5.  Positiveness of purified protein derivatives in rheumatoid arthritis patients who are not receiving immunosuppressive therapy.

Authors:  Ilhan Sezer; Hilal Kocabas; Meltem Alkan Melikoglu; Mehmet Arman
Journal:  Clin Rheumatol       Date:  2008-08-08       Impact factor: 2.980

6.  Purified protein derivative test and its booster phenomenon in patients with rheumatoid arthritis.

Authors:  Mansour Salesi; Mohsen Meidani; Shirin Meshkinfar; Hurie Hashemi; Ziba Farajzadegan
Journal:  Adv Biomed Res       Date:  2015-05-08

Review 7.  Latent tuberculosis infection in patients with rheumatic diseases.

Authors:  Camila Anton; Felipe Dominguez Machado; Jorge Mario Ahumada Ramirez; Rafaela Manzoni Bernardi; Penélope Esther Palominos; Claiton Viegas Brenol; Fernanda Carvalho de Queiroz Mello; Denise Rossato Silva
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624

8.  Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline--a longitudinal analysis after using TNFa blockers.

Authors:  Carina Mori Frade Gomes; Maria Teresa Terreri; Maria Isabel de Moraes-Pinto; Cássia Barbosa; Natália Pereira Machado; Maria Roberta Melo; Marcelo Medeiros Pinheiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11       Impact factor: 2.743

9.  Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.

Authors:  Lamia Oulkadi; Samira Rostom; Ihsane Hmamouchi; Salma El Hassani Sbai; Imane El Binoune; Bouchra Amine; Redouane Abouqal; Fadoua Allali; Lahsen Achemlal; Imane El Bouchti; Abdellah El Maghraoui; Imad Ghozlani; Hasna Hassikou; Taoufik Harzy; Linda Ichchou; Ouafae Mkinsi; Redouane Niamane; Rachid Bahiri
Journal:  Rheumatol Int       Date:  2021-06-26       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.